Skip to main content
Contenidos

Scientific Abstracts

Use Container
1
Padding
10
Alinear textos
center
No padding phone
1
Contenido Full

Key Dates for the Submission of Abstracts

The PANLAR 2026 Congress is approaching, and we want to make sure you don’t miss any of the critical dates for submitting your research. The platform to upload and submit abstracts will be available very soon, and we will share more information shortly.

Please note that the abstract submission deadline is December 29, 2025, and there will be no extensions. Closing time: 6:00 P.M. (GMT-5), Panama City time.

Use Container
1
Padding
10
Alinear textos
center
No padding phone
1
Card contents
Texto
Submission 
Deadline
December 29th 2025
6:00 P.M. Panama City time
Card contents
Texto
Notification 
to Authors
February 13th, 2026
Card contents
Texto
Presenting author 
discount deadline
February 25th, 2026
Card contents
Texto
E-poster file 
submission Deadline
February 25th, 2026
Use Container
1
Padding
10
No padding phone
1

Regulations

Use Container
1
Padding
10
Alinear textos
center
No padding phone
1
Contenido Full

1. DEADLINE: The deadline for submitting papers is December 29, 2025, at 6:00 p.m. Panama. There will be no extension.

All abstracts for the 28th Pan-American Congress of Rheumatology shall be submitted electronically through the system that will be set up for this purpose. Papers may not be submitted by fax, hard copy, or email.

2. REGISTRATION: You may submit your paper without being registered for the congress. The presenting author shall be registered to make their presentation during the congress.

If your paper is accepted, the presenting author will have access to the early bird rate until February 25, 2026, to register for the congress.

3. PUBLICATION: Accepted papers will be published in the PANLAR journal Global Rheumatology.

4. ABSTRACT LIMIT: There are no restrictions on the number of abstracts an author can submit or
present at the conference.

5. LANGUAGE: Abstracts shall be written in English. Tables, figures, and abbreviations shall be in English. Abstracts that are not in English will not be evaluated.

If you are not fluent in English, seek help in writing your abstract. Poor English writing will be grounds for rejection.

Once the abstract is accepted, the PPT (for oral presentation) or E-Poster shall be in English. The presentation at the congress may be in Spanish, Portuguese, or English.

6. CHARACTERISTICS: Use clear language, avoiding complex characters or formulas.

Abstracts should be structured as follows: Background/Objective, Methods, Results, Conclusion.

7. CHARACTER LIMIT: The limit is 2,750 characters for the text of your abstract and references, including spaces and punctuation (this does not include author information, title, keywords nor tables).

You may include 1 image and 1 table; or 2 images, or 2 tables. Figures, tables, and images included in the abstract shall be referenced in the text. Tables shall be created using the corresponding tool in the form; they should not be uploaded as images.

8. EVALUATION: To preserve the peer review process, do not include any information (e.g., authors' names or institutions) in the body of your work.

9. REFERENCES: These are not mandatory (we advise against their use). In the exceptional case of using them, the limit is two (2), adopting the standard format of the publication (Global Rheumatology).

10. CITATIONS: Shall strictly comply with Vancouver standards, numbered consecutively in the order of appearance in the text, in Arabic numerals in parentheses and not as superscript or subscript.
Example:

Author(s) name, Article title. Journal or book title. Volume, issue, year, Pages. Available at: URL.

11. Follow the instructions on the screen to access the submission form. Complete all fields on the form.

12. DECLARATION: The system will ask the submitter to complete a declaration of relevant funding sources to finalize the submission.

13. TOPIC: You should select the appropriate topic from the following options:

1. Psoriatic Arthritis
2. Rheumatoid Arthritis
3. Crystal Arthropathies
4. Basic Sciences and Immunology
5. Education in Rheumatology
6. Infection-related Rheumatic Diseases (including COVID-19)
7. Epidemiology (including socioeconomic, sociocultural, and gender equity studies)
8. Systemic Sclerosis and Interstitial Lung Disease
9. Axial and Peripheral Spondyloarthritis
10. Fibromyalgia and Pain
11. Imaging in Rheumatology
12. Systemic Lupus Erythematosus
13. Inflammatory Myopathies
14. Osteoarthritis and Mechanical Musculoskeletal Pathologies
15. Osteoporosis and Metabolic Bone Diseases
16. Pediatric Rheumatology
17. Antiphospholipid Syndrome
18. Sjögren's Syndrome and Other Systemic Autoimmune Diseases
19. Systemic Vasculitis
20. Miscellaneous Diseases

The decision on the type of presentation will be made by the Evaluation Committee.

14. AUTHORS: Please enter the names of the authors in the order in which they should appear in the header of the paper.

It is the responsibility of the person submitting the paper to correctly write the full names of the other authors, which will be reproduced on the certificate as submitted (if accepted).

The presenter of the paper shall be a co-author. It is not permitted to edit the list of authors after the deadline for receipt of abstracts.

*The organization will not edit the authors' data or the content of the abstracts*

Confirmation of receipt of the paper will be sent to the email address provided in the paper

The contact author will receive all notifications related to the paper and will be responsible for informing the co-authors of its status.

15. REVIEWING YOUR ABSTRACT: Review your paper carefully. Make sure that all special characters and formatting appear correctly in your final proof. If you find any errors, return to the corresponding page to correct them. It is the author's responsibility to submit the paper correctly.

16. FINAL SUBMISSION: Once all fields have been completed, papers can be saved in “Final Submission” status. Only abstracts saved in “Final Submission” will be considered successfully submitted and considered for the Congress. Papers submitted or saved as in progress or drafts cannot be edited after the submission deadline.

CANCELED papers will not be considered for evaluation.

17. NOTIFICATIONS: will be sent by email in mid-February 2026.

The decision of the Evaluation Committee will be final and there will be no instances of review of the evaluation.

18. PRESENTATION: For accepted abstracts, the presenting author shall present the paper in person on the day and at the time assigned at the Congress.

19. CERTIFICATE: A single certificate will be issued per paper, which will include all authors in the order in which they were submitted.

20. TECHNICAL SUPPORT: If you encounter any difficulties during the submission process, please contact scientific-secretariat@wearemci.com.

21. Papers previously presented at other conferences: may be accepted at the PANLAR 2026 conference as long as the copyright of the other event, conference, or congress is not violated.

Authors are strongly encouraged to add new data generated between the previous presentation and the PANLAR 2026 abstract submission deadline.

If your abstract has been presented at another conference, it will only be considered for poster presentation by the organizing committee.

If the paper has been previously presented at another conference, this shall be indicated in the
corresponding section.

 

PANLAR RECOMMENDATIONS
Before submitting your work, please note the following:

- Take time to write: Be sure not to leave writing your abstract until the last minute before the deadline. Proper planning will allow you to submit a more complete and higher quality paper.

- Read and follow the instructions: To increase your chances of selection, it is essential to comply with all the guidelines and requirements set out in the initial instructions provided by the evaluation committee. This includes aspects such as the format of tables and figures, as well as any other specific details indicated in the guidelines.

- Review the English wording: Remember that papers shall be submitted in English. Assess your language skills and, if necessary, seek help from competent reviewers to ensure the accuracy and quality of the English writing in your abstract.

- Clarity and scientific rigor: Make sure your abstract is clear, concise, and focuses on the most important aspects of your research. Maintain a focus on scientific rigor and, when presenting clinical cases, highlight practical lessons for the specialty

- Comply with thematic requirements: Ensure that your abstract is aligned with the thematic areas and methodologies relevant to the Congress. Ensure that your work fits the specific categories announced for the event.

- Planning and review: Do not underestimate the importance of thorough planning and review. Take the time to review and correct your abstract before submitting it. This will ensure the quality and accuracy of your presentation.

- References and citations: Be sure to follow the appropriate citation and reference standards in your abstract, if applicable.

- Maintain high ethical standards in the presentation of scientific work.

- Final review: Before submitting your abstract, perform a final review to ensure that it complies with all of
the guidelines and recommendations mentioned above.

 

Use Container
1
Padding
10
Alinear textos
left
No padding phone
1
Contenidos
BG Color Block
#4b4b4b
ImageNoStyle
Image
Panlar
Card elements selector
Card elements
Card elements selector
Card elements
Information
Use Container
1
Padding
40
No padding phone
1